Team
LEADERSHIP
Led by biotech entrepreneurs with deep domain expertise.
Topher Kinsella, MD
CEO & CO-FOUNDER
15+ years in medicine and medical product innovation
Trauma and acute care surgeon
Stanford Biodesign Alumnus
Innovator behind the REBOA trainer, used by leading hospitals
Vikas Agarwal, PhD
CHIEF DEVELOPMENT OFFICER
25+ years drug development with deep 505(b)(2) and combination product expertise
Program Lead, TARIS Biomedical
(Acquired by J&J 2019)
Led development of first-in-class intravesical drug-delivery platform from R&D to clinical development across four indications.
Joaquim Trias, PhD
BOARD MEMBER
25 years in BioPharma with multiple M&As
Elaine Heron, PhD
BOARD MEMBER
30+ years in life sciences; multiple raises & exits
Rush Bartlett, PhD
BOARD MEMBER
20+ years as a medtech founder with 30+ patents
Clay Nolan
BOARD MEMBER
Watershed Co-Founder and CEO of CoLabs Medical
ADVISORS + KOLS
Advised and endorsed by urology industry leaders.
Lynn Gold, PhD
ADVISOR
Regulatory Affairs
35+ years, 27 Approved NDAs
David Perry
ADVISOR, DEVICES
30+ years in the medical device sector, CEO Urotronic
Jeff Dann, MD
ADVISOR, REIMBURSEMENT
Prev. Chairman of AUA Coding and Reimbursement Comm.
Art Tipton, PhD
ADVISOR, POLYMER SCIENTIST
Vulcan Gray (Principal), Evonik (H of Drug Delivery)
Lauren Nelson
ADVISOR, COMMERCIALIZATION
Head of Market Access & Trade
Paul Westberg
ADVISOR, BUSINESS OPS
$400m+ in licensing
$200m+ in capital raise
Steven Kaplan, MD
KEY OPINION LEADER
Urology Oncology
Rush University
Roger Dmochowski, MD
KEY OPINION LEADER
Prof. of Urology
Vanderbilt University
Rich Babayan, MD
KEY OPINION LEADER
Former President of the AUA and former Chair of Urology at BU
A. Lenny Ackerman, MD
KEY OPINION LEADER
Female Pelvic Medicine, leader in UTI and Bladder Microbiome
Karyn Eilber, MD
KEY OPINION LEADER
Prof. of Urology and Assoc. Prof. OBGYN at Cedars-Sinai Medical
Suzette Sutherland, MD
KEY OPINION LEADER
Dir. Female Urology
Prof. of Urology at U. Washington
